Index of reports
> Cases with Foetal Exposure During Pregnancy (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Viracept (Nelfinavir) where reactions include foetal exposure during pregnancy. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Viracept side effects in
Reported by a physician from United States on 2012-02-21
Patient: , weighing 2.4 kg (5.3 pounds)
Reactions: Ileal Atresia, Premature Baby, Foetal Exposure During Pregnancy
Drug(s) suspected as cause:
Stavudine
Dosage: 80mgd per day
Indication: Antiretroviral Therapy
Viracept
Dosage: 1250mgd per day
Indication: Antiretroviral Therapy
Epivir
Dosage: 300mgd per day
Indication: Antiretroviral Therapy
Possible Viracept side effects in
Reported by a physician from United States on 2012-02-06
Patient: , weighing 2.4 kg (5.3 pounds)
Reactions: Ileal Atresia, Premature Baby, Foetal Exposure During Pregnancy
Drug(s) suspected as cause:
Epivir
Dosage: 300mgd per day
Indication: Antiretroviral Therapy
Stavudine
Dosage: 80mgd per day
Indication: Antiretroviral Therapy
Viracept
Dosage: 1250mgd per day
Indication: Antiretroviral Therapy
|